Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C13H16N2O |
| Molecular Weight | 216.2789 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C1C2=CC=CN=C2O[C@]13CN4CC[C@H]3CC4
InChI
InChIKey=OCKIPDMKGPYYJS-ZDUSSCGKSA-N
InChI=1S/C13H16N2O/c1-2-10-8-13(16-12(10)14-5-1)9-15-6-3-11(13)4-7-15/h1-2,5,11H,3-4,6-9H2/t13-/m0/s1
| Molecular Formula | C13H16N2O |
| Molecular Weight | 216.2789 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 01:27:16 UTC 2023
by
admin
on
Sat Dec 16 01:27:16 UTC 2023
|
| Record UNII |
2B218X5QIY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2B218X5QIY
Created by
admin on Sat Dec 16 01:27:16 UTC 2023 , Edited by admin on Sat Dec 16 01:27:16 UTC 2023
|
PRIMARY | |||
|
DTXSID40944616
Created by
admin on Sat Dec 16 01:27:16 UTC 2023 , Edited by admin on Sat Dec 16 01:27:16 UTC 2023
|
PRIMARY | |||
|
CHEMBL2151437
Created by
admin on Sat Dec 16 01:27:16 UTC 2023 , Edited by admin on Sat Dec 16 01:27:16 UTC 2023
|
PRIMARY | |||
|
NCT00669903
Created by
admin on Sat Dec 16 01:27:16 UTC 2023 , Edited by admin on Sat Dec 16 01:27:16 UTC 2023
|
PRIMARY | Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia | ||
|
220099-91-2
Created by
admin on Sat Dec 16 01:27:16 UTC 2023 , Edited by admin on Sat Dec 16 01:27:16 UTC 2023
|
PRIMARY | |||
|
9794392
Created by
admin on Sat Dec 16 01:27:16 UTC 2023 , Edited by admin on Sat Dec 16 01:27:16 UTC 2023
|
PRIMARY | |||
|
AZD0328
Created by
admin on Sat Dec 16 01:27:16 UTC 2023 , Edited by admin on Sat Dec 16 01:27:16 UTC 2023
|
PRIMARY | |||
|
DB12145
Created by
admin on Sat Dec 16 01:27:16 UTC 2023 , Edited by admin on Sat Dec 16 01:27:16 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> AGONIST |
Promising compounds acting as a α7 nAChR selective agonists seem to be also AZD0328 and TC-5619, both containing azabicyclooctane group. They are expected to be useful to treating multiple cognitive dysfunctions and schizophrenia .
|
